MicroX Labs
MicroX Labs aims to improve health and survival rates in cancer care by developing innovative point-of-care diagnostic solutions. Their primary product, HomeCyteTM, is a portable blood analyzer designed for frequent monitoring during oncology treatments. HomeCyteTM consists of a reader, disposable cartridges, and a microfluidics impedance cytometer, capable of performing CBC in under 7 minutes and protein marker tests in under 20 minutes. The solution leverages machine learning algorithms to analyze cellular data, offering benefits such as reduced infection risks, enhanced patient comfort, cost savings, and time efficiency for clinicians. The company is focused on providing value to both patients and healthcare providers, enabling remote patient monitoring and improving chronic care management.
MicroX Labs
MicroX Labs aims to improve health and survival rates in cancer care by developing innovative point-of-care diagnostic solutions. Their primary product, HomeCyteTM, is a portable blood analyzer designed for frequent monitoring during oncology treatments. HomeCyteTM consists of a reader, disposable cartridges, and a microfluidics impedance cytometer, capable of performing CBC in under 7 minutes and protein marker tests in under 20 minutes. The solution leverages machine learning algorithms to analyze cellular data, offering benefits such as reduced infection risks, enhanced patient comfort, cost savings, and time efficiency for clinicians. The company is focused on providing value to both patients and healthcare providers, enabling remote patient monitoring and improving chronic care management.